Pharmaceutical and life sciences database/analytics vendor IMS Health has filed an S-1 registration statement with the Securities and Exchange Commission to conduct an initial public offering of stock with a preliminary goal of raising $100 million.

That figure is a placeholder number for now, and published reports say the firm could raise up to $1 billion. The number of shares being offered and price range has not been determined. The company intends to use the proceeds to repay a part of its long-term debt and for general corporate purposes, according to its announcement.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access